Oscar Health (NYSE:OSCR) Shares Down 4.2% – What’s Next?

Oscar Health, Inc. (NYSE:OSCR)’s stock price traded down 4.2% during trading on Wednesday . The company traded as low as $14.25 and last traded at $14.03. 487,889 shares changed hands during trading, a decline of 86% from the average session volume of 3,575,779 shares. The stock had previously closed at $14.65.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $20.00 to $16.00 in a research report on Thursday. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $20.19.

Oscar Health Stock Down 9.1 %

The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.23 billion, a P/E ratio of -644.93 and a beta of 1.75. The business’s 50 day moving average is $15.23 and its 200 day moving average is $16.43.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

A number of institutional investors have recently modified their holdings of OSCR. Vanguard Group Inc. raised its stake in shares of Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock worth $255,333,000 after acquiring an additional 586,626 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its holdings in shares of Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after purchasing an additional 8,051,379 shares in the last quarter. Thrive Capital Management LLC grew its stake in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC increased its position in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after buying an additional 2,151,256 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.